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SYNOPSIS 
Excitation contraction coupling is the physiological mechanism occurring in muscle cells 
whereby an electrical signal sensed by the dihydropyridine receptor located on the transverse 
tubules is transformed into a chemical gradient (Ca2+ increase) by activation of the ryanodine 
receptor located on the sarcoplasmic reticulum membrane. In the present investigation we 
characterized for the first time the excitation contraction coupling machinery of an immortalized 
human skeletal muscle cell line. Intracellular Ca2+ measurements showed a normal response to 
pharmacological activation of the ryanodine receptor whereas super resolution structured 
illumination microscopy (3D-SIM) revealed a low level of structural organization of ryanodine 
receptors and dihydropyridine receptors. Interestingly, the expression levels of several transcripts 
of proteins involved in calcium homeostasis and differentiation indicate that the cell line has a 
phenotype closer to that of slow twitch than fast twitch muscles. These results point to the 
potential application of such human muscle-derived cell lines to the study of neuromuscular 
disorders; in addition they may serve as a platform for the development of therapeutic strategies 
aimed at correcting defects in calcium homeostasis due to mutations in genes involved in 
calcium regulation. 
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INTRODUCTION 
Skeletal muscle is a highly differentiated tissue made up of myofibers, a syncytium of 
cells filled with myofibrils and containing sarcomeres that generate the force necessary for 
muscle contraction. During the past few years a number of techniques have been developed to 
isolated single muscle fibers from small rodents allowing detailed investigations of the functional 
properties of the excitation contraction (EC) coupling mechanism at the ultrastructural, 
biochemical and cellular levels in normal and pathological conditions [1-4]. Because of their 
high degree of differentiation and specialization, it is difficult to maintain differentiated muscle 
fibers in culture for more than a few days [5] and it is nearly impossible to obtain mature fibers 
starting from precursor satellite cells. Nevertheless, starting from newborn mice one can obtain 
cultures of contracting and striated myotubes that can be used for a number of manipulations. As 
to human muscle cells, primary cultures can be obtained in vitro by culturing satellite cells from 
biopsies and differentiating them into myotubes [6-9], but there is a clear necessity to develop 
cell lines from control and diseased individuals which will develop into myotubes and which can 
be exploited as a platform for drug screening, and for biochemical, cellular and physiological 
characterization [10-13].  
For the past two decades our laboratory as well as others, have established primary 
cultures from human biopsies and characterized their intracellular Ca2+ homeostasis, with 
particular emphasis on EC coupling, how endogenous mutations in the ryanodine receptor Ca2+ 
channel (RyR1) affect its functional properties and some downstream effects of calcium 
dysregulation such as subcellular localization of the transcription factor NFAT, pro-
inflammatory cytokine release and production of reactive nitrogen species [9,14,15]. However, 
the use of primary cultures has some inherent drawbacks mainly relating to the fact that they are 
generally slow growing and will undergo a limited number of divisions. To overcome this 
problem, immortalization of human myogenic cells has recently been established both from a 
normal individual [16,17] as well as from patients with different neuromuscular diseases [17-20]. 
In the present study we characterized a new cell line derived from a normal individual with no 
overt neuromuscular disorder. We show that the myotubes derived upon differentiation by serum 
withdrawal express the transcripts and protein components of the skeletal muscle EC coupling 
machinery. In addition, we established by super resolution structured illumination microscopy 
(3D-SIM) the subcellular distribution of the RyR1 and of the dihydropyridine receptor and 
assessed calcium release via RyR by using optical and electrophysiological techniques. This 
human skeletal muscle cell line HMCL-7304 is a tool of paramount importance to study on a 
larger scale the changes occurring in human muscles under a variety of pathological conditions. 
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EXPERIMENTAL PROCEDURES 
Cell culture: The immortalized myoblast cell line was established from the intercostals skeletal 
muscle biopsy of a 19-year-old female donor with no	   neuromuscular disorder by double 
transfection with recombinant retroviruses containing the telomerase (hTERT) cDNA and Cdk4 
cDNA, as previously described [16,17]. Immortalized myoblasts were maintained in skeletal 
muscle cell growth medium (PromoCell GmbH, Heidelberg, Germany; catalogue N° c-23060) in 
low oxygen atmosphere (5% O2 and 5% CO2) at 37º C. In order to induce differentiation, once 
the density had reached approximately 80%, cells were rinsed one time with Phosphate Buffered 
Saline (PBS, pH 7.2; Life Technologies, Lucerne, Switzerland) and incubated with skeletal 
muscle differentiation medium (PromoCell GmbH, Heidelberg, Germany; catalogue N° c-
23061). The process of differentiation took on average 5 days after which multinucleated 
myotubes were clearly visible under low magnification. Henceforward the Human Muscle 
derived-Cell Line will be referred to as HMCL-7304.  
 
[Ca2+] Measurements: HMCL-7304 cells were grown and differentiated on glass cover 
slips coated with laminin (10µg/ml; Life Technologies, Lucerne, Switzerland). Once myotubes 
had formed, cells were loaded with the fluorescent Ca2+ indicator Fluo-4/AM (Life 
Technologies, Lucerne, Switzerland) for 40 minutes at 37 °C as previously described [15]. Cells 
were rinsed one time with Krebs-Ringer containing 2 mM CaCl2 and then coverslips were 
mounted onto a 37ºC thermostated chamber which was continuously perfused with Krebs Ringer 
medium; individual cells were stimulated with the indicated agonists (KCl, 4-chloro-m-cresol, 
caffeine) made up in Krebs Ringer containing no added Ca2+ plus 100 µM La3+ in order to 
monitor changes in the cytoplasmic calcium concentration due to release from intracellular 
stores. Individual cells were stimulated by means of an 8-way 100mm diameter quartz 
micromanifold computer-controlled microperfuser (ALA Scientific Instruments, Farmingdale, 
New York, U.S.A.), as previously described [14]. On-line fluorescence images were acquired 
using an inverted Nikon TE2000 TIRF microscope equipped with a dry Plan Apochromat 20x 
objective (N.A. 0.17) and an electron multiplier Hamamatsu CCD camera C9100-13. Changes in 
the free cytosolic calcium concentration were analyzed using MetaMorph (Molecular Devices) 
imaging system and the average pixel value for each cell was measured as previously described 
[14,15]. 
 
Electrophysiological measurements and confocal Ca2+ imaging:  Myoblasts were 
grown on laminin-coated glass-bottom 35 mm dishes (MatTek). After differentiation into 
myotubes, cells were patch-clamped in the whole-cell configuration with low-resistance 
borosilicate glass micropipettes (1-3 MΩ) using an Axopatch 200B amplifier (Axon Instruments, 
Union City, CA) controlled by a custom-written data-acquisition software developed by 
LantibodiesView (National Instruments, Austin, TX). The external solution contained (in mM): 
150 TEA-CH3SO3, 2 CaCl2, 1 MgCl2, 10 HEPES, 0.001 TTX, 1 4-AP, pH was adjusted to 7.4 
with CsOH. The pipette solution contained (in mM): 140 Cs-CH3SO3, 10 HEPES, 6 MgCl2, 11.5 
CaCl2, 4 Na2ATP, 20 EGTA, 14 CrPO4, 0.1 Leupeptin, 0.1 K5-Fluo-3, pH was adjusted to 7.2 
with CsOH (21). The reference electrode was connected to the bath solution with an agar bridge 
(4% agar in 3 M KCl). All measurements were done at room temperature. Holding potential was 
kept at –80 mV. Step-wise depolarizations were applied to activate the voltage-dependent 
dihydropyridine receptor (DHPR) and to trigger Ca2+ release mediated by the ryanodine receptor 
(RyR1), the intracellular Ca2+-release channel located in the sarcoplasmatic reticulum (SR) 
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membrane. Detailed voltage-clamp protocols are indicated. In order to determine the current-
voltage relationship, long depolarizations of 800 ms were applied. Currents were analyzed in 
IgorPro (Wavemetrics, Lake Oswego, OR). Peak current amplitude was calculated from the 
difference between membrane currents before and during application of 500 mM CdCl2 (ΔICaL). 
For the investigations of electromechanical coupling between DHPR and RyR1, short 
depolarizations (50 ms) were applied. Changes in intracellular Ca2+ levels [Ca2+]i were 
monitored using the fluorescent Ca2+ indicator fluo-3 (Biotium), which was loaded into the cell 
via the patch pipette. Using a laser-scanning confocal microscope (MicroRadiance, Biorad, 
Hercules, CA), fluo-3 was excited at 488 nm with an argon ion laser, and emission light was 
collected above 500 nm. Linescan images were recorded at a rate of 50 lines/sec, analyzed in 
ImageSXM (free software based on NIH Image) [22] and further processed using IgorPro. 
Changes in [Ca2+]i are shown as relative changes in fluorescence (ΔF/F0).  
 
qPCR experiments: Total RNA was extracted from differentiated HMCL-7304 myotubes and 
biopsies from healthy individuals, using Trizol (Life Technologies, Lucerne, Switzerland) as 
previously described [23]. cDNA was synthesized with the High Capacity cDNA synthesis kit 
(Applied Biosystem) and the following primers: RYR1 (Forward : 5’ -ATC TCC CGC CTT 
AGC CAT ACT TCT -3’ and Reverse:  5’ -GGA CCT CTA CGC CCT GTA TC- 3’); RYR3 
(Forward 5’-CAG TCC CTA TCT GTC AGA GCC -3’ and Reverse 5’- CAT GGC CGT ATA 
ACA GGG TCC -3’) ; CAV 1.1 (Forward: 5’-ACG AAC ATG CAC CTA GCC AC- 3’ and 
Reverse 5’- ACG AAC ATG CAC CTA GCC AC- 3’) ; CASQ 1 (Forward: 5’-CAC CCA AGT 
CAG GGG TAC AG- 3’ and Reverse: 5’-GTG CCA GCA CCT CAT ACT TCT- 3’) ; CASQ 2 
(Forward 5’-CAT TGC CAT CCC CAA CAA ACC -3’ and Reverse 5’-AGA GTG GGT CTT 
TGG TGT TCC -3’); DES 1 (Forward 5’ -AAC CAG GAG TTT CTG ACC ACG -3’ and 
Reverse: 5’- TTG AGC CGG TTC ACT TCG G -3’); MYH 1 (Forward 5’- GGG AGA CCT 
AAA ATT GGC TCA A -3’ and Reverse 5’- TTG CAG ACC GCT CAT TTC AAA -3’); MYH 
2 (Forward 5’- AGA AAC TTC GCA TGG ACC TAG -3’ and Reverse 5’- CCA AGT GCC 
TGT TCA TCT TCA -3’); SERCA 1 (Forward 5’-GGT GCT GGC TGA CGA CAA CT -3’ and 
Reverse 5’-AAG AGC CAG CCA CTG ATG AG -3’); SERCA 2 (Forward 5’-CTC CAT CTG 
CCT GTC CAT-3’ and Reverse 5’-GGC TGA CGG CTT CCA AGT-3’). Transcript levels were 
quantified using Syber Green reagent on an Applied Biosystems platform (7500 fast real time 
PCR system) and levels were normalized to Desmin expression.  
 
Mouse muscle fiber isolation: Mouse flexor digitorum brevis (FDB) fibers were enzymatically 
dissociated at 37°C for 60 min in a cell culture incubator in Tyrode’s solution containing 0.20% 
collagenase I (Sigma Fine Chemicals, St. Louis, M.O., U.S.A.; catalogue N° C0130-16) and 
placed on glass coverslips previously coated with 1.5 µl laminin (1 mg/ml) (catalogue N° 23017-
015; Life Technologies, Lucerne, Switzerland) as previously described [23].  
 
Immunofluorescence: For immunofluorescence, myotubes cultured on glass coverslips were 
fixed with 4% paraformaldehyde at room temperature for 15 min, washed and permeabilized 
with 0.1% Triton-PBS for one hour before blocking with 3% goat serum for 30 min, followed by 
one hour incubation in mouse anti-fast myosin monoclonal antibody (1:100; Sigma Fine 
Chemicals, St. Louis, M.O., U.S.A.; catalogue N° M4276) and mouse anti-slow myosin 
monoclonal antibody (1:50; Novo NCL, Leica Biosystem, Newcastle, UK, catalogue N° NCL-
MHC) at room temperature. Coverslips were washed in 0.1% Triton-PBS and incubated with 
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goat-anti-mouse secondary antibody conjugated to Alexa Fluor 594 (Life Technologies, Lucerne, 
Switzerland, catalogue N° A-11005), for one hour at room temperature, followed by thorough 
washing in PBS. Nuclei were stained with Hoechst 33258 (Invitrogen, catalogue N° H3569) for 
10 min. Slides were mounted in aqueous mounting medium and viewed with a Leica DMR 
fluorescent microscope equipped with a 20x HC-PL Fluotar objective (N.A.0.50). The 
percentage of fast and slow myosin positive HMCL-7304-derived myotubes was calculated by 
counting the number of myosin positive cells divided by the total numbers of cells as visualized 
by brightfield microscopy in the same area. For super resolution microscopy, FDB fibers or 
human skeletal muscle myotubes were fixed with 3.7% paraformaldehyde (in PBS) for 30 min at 
room temperature, rinsed 2 x with PBS and permeabilized with 1% Triton-X 100 in PBS for 30 
min. After rinsing and blocking non specific sites with 1:100 Roche blocking solution, cells and 
fibers were incubated with the following antibodies for 3 hours at room temperature (final 
concentration 10 µg/ml diluted in PBS+ 0.01% Tween): mAb anti-RyR1 (Thermo Scientific, 
Catalogue N° MA3-925), goat anti- Cav1.s (Santa Cruz, catalogue N° sc-8160). Slides were 
rinsed with PBS-T 5 times 5 min each and incubated with the appropriate secondary conjugate 
(Alexa Fluor 555; Alexa Fluor 647, Life Technologies, Lucerne, Switzerland, 1:500 diluted in 
PBS-T) over night at 4°C. Slides were rinsed with PBS-T and mounted with 10% glycerol in 
PBS. Staining was visualized with a Zeiss Elyra microscope equipped with 63X oil Plan-
Apochromat (1.4 N.A.) objective. Raw data sets consisted of images acquired with three 
different grid angles and 5 different grid phases. Super resolution images were calculated from 
the raw data using the build-in algorithm. The baseline was just shifted (not truncated) to allow 
inspection for potential ghosts arising from sample imperfections.  
 
Electrophoresis and immunoblotting: Microsomes were prepared from differentiated HMCL-
7304 derived myotubes as previously described [24]. Protein concentration was determined using 
the BioRad kit (catalogue N° 500-0006) using bovine serum albumin as a standard. SDS-PAGE, 
protein transfer onto nitrocellulose and immunostaining were performed as previously described 
[24]. The following primary antibodies were used: mouse anti-RyR1 (Thermo Scientific, MA3-
925), rabbit anti-RyR1 (a kind gift of Prof. V. Sorrentino), goat anti-Cav1.1 (Santa Cruz, 
catalogue N° sc-8160), rabbit anti-CASQ1 (Sigma, catalogue N° CO743), rabbit anti-CASQ2 
(Epitomics, catalogue N° 29621), goat anti-SERCA1 (Santa Cruz catalogue N° sc-8093), goat 
anti-SERCA2 (Santa Cruz catalogue N° sc-8095), mouse anti-MYH1 (Millipore catalogue N° 
MAB S1628). Secondary peroxidase-conjugates were Protein-G POD (Sigma catalogue N° 
8170) and anti-mouse POD (Sigma catalogue N° 2304). The immunopositive bands were 
visualized by chemiluminescence using the Super Signal West Dura kit (Thermo Scientific). 
  
Statistical analysis and graphic software: Statistical analysis was performed using the 
Student's t test; means were considered statistically significant when the P value was <0.05. 
When more than two groups were compared, analysis was performed by the ANOVA test 
followed by the Bonferroni post hoc test using Graphpad Prism 4.0 software. The Origin 
software was used to generate dose response curves and obtain EC50 values; images were 
assembled using Adobe Photoshop CS Version 8.0. 
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RESULTS 
 
Expression levels of proteins involved in excitation-contraction coupling in cell line-derived 
myotubes.  
In order to functionally characterize the HMCL-7304 –derived myotubes, we chose 
several genes that are well known to play a crucial role in skeletal muscle EC coupling. 
Transcript levels were quantified and compared to those present in muscle biopsies obtained 
from five healthy individuals. Figure 1A shows the relative expression levels on a logarithmic 
scale, of different transcripts. Interestingly, we found that the RYR1 transcript was significantly 
lower (approximately 300 times) compared to differentiated muscle (P<0.0001), and there was 
no up-regulation of RYR3 mRNA, which was also significantly reduced in HMCL-7304 
myotubes. SERCA1 and CSQ1 transcript levels were significantly lower (≈1000 times) in the cell 
line (P<0.003), whereas there was a 10-fold increase in the expression of the CSQ2 transcript. 
SERCA2 showed similar mRNA levels in the biopsies and the cell line as did Cav1.1, suggesting 
that expression of the L-type Ca2+ channel may appear at an early stage of development. The 
transcript level of myosin heavy chain 1 (MYH1) and myosin heavy chain2 (MYH2), that are 
characteristically expressed in slow twitch and fast twitch muscles respectively, were lower in 
HMCL-7304 compared to biopsies however, immunofluorescence shows that the slow myosin 
isoform is present in a larger percentage of HMCL-7304 cells, compared to fast myosin, with a 
ratio of approximate 51% (slow) to 13% (fast) (36% negative for both fast and slow isoforms) 
(Fig.1 B). Taken together these results suggest that the differentiated myotubes express proteins 
that are more abundant in slow twitch muscles. 
We are aware that the presence of a transcript does not necessarily reflect protein 
expression, thus we tested microsomes prepared from HMCL-7304-derived myotubes by 
immunoblotting. Figure 1C confirms that MYH1, SERCA1, SERCA2, Cav1.1 and RyR1 were all 
expressed. The double immunopositive band seen in the RyR1 western blot does not represent 
RyR3 since both bands were present when a RyR1 specific polyclonal antibody was used; thus 
the lower band is probably a degradation product. No bands were visualized when blots were 
probed with anti-CSQ1 antibodies (not shown) but a band migrating with an approximate 
molecular mass of 55 kDa (asterisk) was present when myotube microsomes were probed with 
anti-CSQ2 antibodies.  
 
Cellular localization of EC coupling proteins:  
In mature skeletal muscle, EC coupling occurs and is fully dependent on the architecture of 
highly structured intracellular calcium release units, whereby the voltage sensing L-type Ca2+ 
channel is present in the transverse tubules and faces the terminal cisternae of the sarcoplasmic 
reticulum, containing the RyR1 Ca2+ release channels. The sarcoplasmic reticulum contains the 
calcium binding protein calsequestrin, whereas the SERCA Ca2+ pumps are located on the 
longitudinal sarcoplasmic reticulum. In order to define the cellular localization of these proteins 
in mature myotubes, we used a super resolution (Structured Illumination Microscopy, 3D-SIM) 
microscope, because compared to conventional confocal fluorescence microscopy and 
Stimulated Emission Depletion microscopy it offers improved lateral (approx. 100 nm) and axial 
resolution (approx. 300 nm) [25]. Figure 2 shows the immunostaining of Cav1.1 and RyR1 both 
in myotubes (A-F) and in enzymatically dissociated mouse FDB fibers (G-I). As expected in 
FDB fibers the staining with anti-Cav1.1 shows a double row of fluorescent particles (Fig. 2G) 
that mostly overlap with particles which are stained with anti-RyR1 antibodies (Fig. 2H). Human 
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myotubes also show fluorescent particles whose distribution does not follow the highly regular 
pattern observed in mature FDB fibers. However, when observed at high magnification it 
becomes apparent that human myotubes display areas containing multiple parallel longitudinal 
rows of fluorescence particles which are stained anti-Cav1.1 antibodies (Fig. 2D double arrows). 
A large fraction of particles stained with anti-Cav1.1 antibodies co-localize with particles stained 
with anti-RyR1 antibodies (Fig. 2F arrowheads) and may represent calcium release units 
involved in EC coupling. In the next set of experiments, we assessed the EC coupling 
characteristics of HMCL-7304-derived myotubes, by studying RyR- mediated Ca2+ release and 
Cav1.1 mediated Ca2+ currents either by optical methods or by using the patch-clamp technique 
in the whole-cell configuration. 
 
Functional properties and pharmacological activation of calcium release:  
 Figure 3 shows the results obtained in cells loaded with the fluorescent Ca2+ indicator 
fluo-4; stimulation of cells with 60 mM KCl caused an immediate increase in the resting [Ca2+] 
which decayed back to resting values within approximately 5 seconds (Fig 3B); the peak increase 
in [Ca2+] was similar irrespective of whether cells were stimulated via activation of the DHPR L-
type Ca2+ channel by KCl-induced depolarization, or by direct activation of the RyR1 with 4-
chloro-m-cresol and caffeine (Fig. 3 C). Panels 3D, E and F show dose dependent peak Ca2+ 
release curves elicited by caffeine, 4-chloro-m-cresol and KCl respectively as well as the 
calculated EC50 values. These results are similar to those obtained in primary human muscle 
myotubes explanted from biopsies from control individuals [14,15]. 
We then investigated the voltage-dependence of membrane currents (ICaL) from the 
DHPR in voltage-clamped HMCL-7304 myotubes. Starting from a holding potential of –80 and 
an initial pre-step to –40 mV, cells were stimulated by repetitive depolarizing steps of 800 ms in 
10 mV increments to increasing membrane potentials. Figure 4A shows 5 steps of the 
stimulation protocol (upper trace) and the corresponding membrane currents (below) during 
control conditions (black) and during inhibition of ICaL with Cd2+ (red). The calculated difference 
current (ΔICaL) is indicated in blue and peak current amplitudes at the end of the depolarizing 
steps are used for further analysis. Figure 4B summarizes the voltage-dependence of current 
activation and reveals a half-maximal activation (V1/2) at –9 mV. 
A parallel investigation of electromechanical coupling was achieved using a combination 
of voltage-clamp and confocal Ca2+ imaging. Cells were imaged in the linescan mode at close 
proximity to the position of the patch pipette. Membrane depolarization triggered significant 
Ca2+ release, indicating functional coupling between the DHPR and RyR1. Depolarization-
induced Ca2+ release was monitored and recorded in linescan images. Figure 5A shows a 
voltage-clamped HMCL-7304 myotube loaded with fluo-3; the position of the linescan is 
indicated in the illustrated myotube. Short depolarization (50 ms) starting from the holding 
potential of -80 mV to +10 mV activated the DHPR and triggered Ca2+ release from the SR. The 
resulting Ca2+ transient is displayed in the linescan image and in the corresponding line profile. 
Of note is the slow return of the [Ca2+] back to resting levels, which might be a consistent with 
low level of SERCA1 expression in immature myotubes (see Figure 1A). As expected, 
increasing membrane depolarization results in greater Ca2+ release, which saturates at a 
membrane potential of around 0 mV. Figure 5B shows the Ca2+ transient amplitude in response 
to increasing depolarization in a single protocol, and Figure 5C summarizes the voltage-
dependence of Ca2+ release. In order to minimize side effects from long periods of scanning and 
accumulation of cytosolic Ca2+ due to slow Ca2+ extrusion processes, data points for peak Ca2+ 
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transients in Figure 5C have been collected from repeated short linescan recordings (6 sec). Ca2+ 
transients elicited under voltage clamp revealed a half-maximal release activation (V1/2) at –32 
mV. 
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DISCUSSION 
 
In the present manuscript we describe the biochemical, cellular and physiological 
characteristics of a novel cell line generated from human skeletal muscle. The necessity to 
establish cell lines of human origin from normal or patients affected by a number of 
neuromuscular conditions has been apparent for the past decades but early attempts to 
immortalize human myoblasts capable of differentiating into mature myotubes were unsuccessful 
(for example see ref. [26 and 27]). Here, we report the successful myotube differentiation from 
myoblasts of the newly generated immortal human muscle cell line HMCL-7304 derived from a 
healthy individual and characterize their features at the biochemical, structural and functional 
level, showing that their phenotype is similar to myotubes from primary cultures. 
In the past few years a number of groups have exploited vectors expressing telomerase- 
and cyclin-dependent kinase 4 and have reported successful immortalization of myoblasts from 
normal individuals and individuals affected by various forms of muscular dystrophies and 
dysferlinopathies [16-20]. The possibility of generating such immortalized cell lines able to 
differentiate into myotubes constitutes an important tool to investigate human neuromuscular 
diseases much like the murine skeletal muscle C2C12 cell line has been exploited during the past 
decades by laboratories worldwide to investigate key aspects of skeletal muscle physiology and 
plasticity. Therefore, there is high demand for a reliable human skeletal cell line to fill the gap 
between understanding the pathophysiological mechanisms and the development of therapeutic 
strategies for human neuromuscular disorders. Nevertheless, though the use of an immortalized 
cell line has many advantages over primary cultures, the process of immortalization is known to 
modify many physiological parameters ranging from differentiation and secretion, to the 
expression of specific protein isoforms. For this reason we characterized the EC coupling 
machinery and Ca2+ homeostasis of HMCL-7304-derived myotubes. We chose to verify the 
levels of expression of the transcripts encoding the main components of skeletal muscle EC 
coupling, as well as their main isoforms and compared them to the levels found in biopsies from 
human skeletal muscle fibers from normal individuals. Transcripts encoding RyR1, calsequestrin 
1 and SERCA1 were significantly down regulated as was RyR3, an isoform that is thought to be 
more abundantly expressed in developing muscles. On the other hand, Cav1.1 was expressed to 
similar levels in both mature fibers and myotubes and produced large Ca2+ currents, as shown in 
patch clamp measurements. These results are in contrast to what occurs during skeletal muscle 
development, where components of the sarcoplasmic reticulum appear at an earlier stage of 
development compared to the transverse-tubules containing the dihydropyridine receptor L-type 
Ca2+ channel [29-31]. Interestingly, the relative mRNA expression of HMCL-7304 derived 
myotubes was either similar to that of mature biopsies (SERCA2) or upregulated (calsequestrin 
2). Thus it seems that the HMCL-7304 cell line has more the characteristics of a “slow twitch” 
than that of a “fast twitch” muscle. This is further confirmed by the predominant expression of 
slow myosin compared to fast myosin in differentiated HMCL-7304 myotubes. Several reasons 
may explain this observation: (i) either satellite stem cells are by default “slow-twitch-like” and 
it is the influence of innervation or electrical activity that enables them to become fast or slow 
[32], (ii) the immortalization procedure “selects” satellite stem cells that have a “slow muscle” 
phenotype, (iii) as reported in hindlimb muscles of adult rats, the satellite cells contained within 
fast or slow twitch fibers are intrinsically different subpopulations [33] so that the HMCL-7304 
cell line that originated from dorsal muscles resembles more a slow-twitch muscle from which it 
originated. 
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Two noticeable differences in the physiological characteristics of human cultured 
myotubes and mature fibers are that primary myotubes do not contract and the time scale of the 
depolarization-induced Ca2+ transient occurs in hundreds of milliseconds in myotubes while it 
lasts only a few millseconds in mature fibers. While the lack of contracture most likely reflects 
the composition of the actomyosin contractile machinery, the slow calcium transients observed 
in myotubes probably reflects the lower level of expression of SERCA1 and the absence of a 
highly organized micro-architecture. After Ca2+ release, cytosolic Ca2+ is rapidly removed and 
pumped back into the SR lumen by the SR Ca2+ ATPase (SERCA), which is the main protein of 
non-junctional SR in skeletal muscle fibers [34]. Reduced SERCA1 expression levels as shown 
in HMCL-7304 cell line have a significant impact on the Ca2+ removal kinetics leading to 
deceleration of Ca2+ re-uptake compared to normal muscle fibers. Thus, lack of mature 
subcellular architectural organization and reduction in SERCA1 expression may explain the slow 
Ca2+ removal after release in the HMCL-7304 cell line. 
In mature fibers four Cav1.1 on the T-tubular face in square formation, referred to as 
tetrads, are directly opposite the four subunits of one RyR1 tetramer on the sarcoplasmic 
reticulum junctional membrane, to form the calcium release units [30]. In intact FDB fibers the 
calcium release units form double rows on each side of the Z line. The highly organized 
arrangement is characteristic of mature skeletal muscle and is probably one of the features 
allowing the extremely rapid Ca2+ release kinetics upon T tubules membrane depolarization.  As 
evidenced by the SIM images, HMCL-7304 myotubes show distinct rows of Cav1.1 that overlap 
at least in part, with RyR1 and we believe that these structures may represent the calcium release 
units of the HMCL-7304 myotubes. This conclusion is consistent with whole patch clamp 
measurements showing that voltage-induced Ca2+ release is highly functional in these myotubes, 
indicating direct coupling between sarcolemmal DHPRs and RyR1 despite structural immaturity. 
HMCL-7304 myotubes exhibit Cd2+-sensitive Ca2+ currents, having half-maximal current 
activation at -9 mV, a value which is comparable to that published by others [35, 36]. Parallel 
imaging revealed that the voltage dependence of Ca2+ release (V1/2) was -32 mV in the present 
report and -29.4 mV in non-immortalized primary human myotubes from control individuals 
[37], which is similar to the values (-26 mV) obtained on primary myotubes from wild type mice 
[38]. Furthermore, the process of immortalization do not affect the pharmacological 
characteristics of RyR1 activation since the caffeine and 4-chloro-m-cresol dose response curves 
of the HMCL-7304 cell line are similar to those of non-immortalized human myotubes [14, 39] 
or RyR1 isolated from mature rodent muscles [40].  
In conclusion in this study we characterized a human muscle cell line derived from a 
normal individual and show that it retains a pattern of expression of proteins involved in EC 
coupling similar to that of slow twitch muscles. The ability to perform pharmacological and 
electrophysiological studies illustrates the potential use of such a biological tool to a variety of 
approaches from studying the effect of mutations and gene silencing to testing drugs and 
pharmacological agents aimed at correcting calcium dysregulation as occurs in a variety of 
neuromuscular disorders including core myopathies. 
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FIGURE LEGENDS 
Figure 1: Expression of excitation-contraction coupling associated proteins in HMCL-7304-
derived myotubes. A. qPCR showing the relative expression levels of the indicated transcripts 
in HMCL-7304-derived myotubes compared to that in mature muscle biopsies. Expression levels 
were normalized for desmin content and are expressed as relative transcript content in 
biopsy/HMCL-7304-derived myotubes. The results are represented as Whisker plots performed 
on 4-5 controls and on the mytoube cell line. ***P<0.0001; **P< 0.07 and *P<0.003 by the 
Student’s t test. B. Immunofluorescence of HMCL-7304-derived myotubes stained with anti- fast 
and slow myosin and DAPI and observed with a Leica DMR fluorescence microscope with a 
20× objective. Scale bar = 50 µm. C. Western Blot analysis of RyR1 and CASQ2 (70 µg/lane), 
CaV1.1, SERCA1, SERCA2, MYH1- myosin heavy chain (50µg/lane). Blots were prepared and 
developed as detailed in the Methods section; for RyR1 the commercial monoclonal Antibodies 
34C as well as the isoform 1 specific RyR polyclonal Antibodies (a kind gift of Prof. Vincenzo 
Sorrentino) recognize the same high molecular weight band corresponding to the RyR. Thus the 
lower less intense immunopositive band probably represents a proteolytic product. * indicates 
CSQ2.  
 
Figure 2:  Cellular localization of RyR1 and Cav1.1 in differentiated myotubes versus 
mouse FDB fibers by SIM microscopy. Human myotubes (A-F) and mouse FDB fibers (G-I) 
were stained with anti-Cav1.1 (A,D,G) and anti-RyR1 (B,E and H) antibodies and examined 
using Zeiss Elyra / ZEN 2010 microscope with a Plan-Apochromat 63x/1.4 Oil 3 rotations. Scale 
bar panels C and I = 5µm; scale bar panel F = 2 µm. Panels D, E and F are higher magnifications 
of the boxed areas shown in panels A, B and C, respectively. Double arrows in panel D represent 
nascent T-tubules; arrowheads in panel F show co-localization of RyR1 and Cav1.1.  
 
Figure 3: Characterization of RyR1-mediated Ca2+ release in HMCL-7304-derived 
myotubes. Myotubes were loaded with 5µM of Fluo-4 and ,Ca2+ release from intercellular stores 
was measured in Krebs Ringer containing no added Ca2+ plus 100 µM La3+ as described in the 
Methods section. A. Photomicrograph of a fully differentiated myotube 5 days after 
differentiation (scale bar = 100 µm) B. Representative Ca2+ transient elicited by the addition of 
KCl; empty line above trace indicates Krebs Ringer containing 100 µM La3+; filled line, 
stimulation with 60 mM KCl in 100 µM La3+. Images were acquired every 100 msec with an 
electron multiplier Hamamatsu CCD C9100-13 camera and data was analyzed using Metamorph 
imaging software (Molecular Devices). C. Peak Ca2+ transients induced by 60 mM KCl, 10 mM 
Caffeine and 600 µM 4chloro-m-cresol; bar histograms represent the mean ± SEM ∆F (peak 
fluorescence –resting fluorescence) of 15 measurements. D-F. Dose response curves to caffeine, 
4-chloro-m-cresol and KCl. Each point represents the mean (± SEM) ∆F of at least 10 different 
myotubes. The data were fitted using a Boltzmann equation using Origin 6.0 software.  
 
Figure 4: Skeletal L-type Ca2+ currents in HMCL-7304. A. Whole-cell patch clamp 
recordings of single HMCL-7304 myotubes: cells were stimulated from a holding potential of –
80 mV and a pre-step to –40 mV to increasing depolarizing potentials (see stimulation protocol). 
Membrane currents (sk ICaL) were recorded in control solution (black trace) and during inhibition 
of ICaL with CdCl2 (500 µM, red trace). Original current traces and calculated difference current 
(ΔICaL, blue trace) are shown. B. Current-voltage relationship of sk ICaL reveals a half maximal 
current activation at –9 ± 0.3 mV. 
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Figure 5: Depolarization-induced Ca2+ release in HMCL-7304 myotubes. A. Patch-clamped 
HMCL-7304 myotube loaded with fluo-3: the area of the linescan recording is indicated. 
Stimulation protocol, current response, line profile and linescan image of the Ca2+ transient are 
displayed in their respective temporal relation. B. Stimulation protocol and line profile of the 
resulting Ca2+ transients in a single protocol reveals the increase in Ca2+ release upon increasing 
membrane depolarization. C. Voltage-dependence of Ca2+ release: Peak Ca2+ transient 
amplitudes have been extracted and plotted in function of the stimulation potential. Half maximal 
Ca2+ release amplitude is achieved at –32 ± 2 mV. 
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